Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Therapeutics Acquisition Corp (RACA) Stock Forecast 2025 - AI Price Prediction & Analysis

Therapeutics Acquisition Corp (RACA) AI Stock Price Forecast & Investment Analysis

Therapeutics Acquisition Corp Stock Price Chart and Technical Analysis

Loading Therapeutics Acquisition Corp interactive price chart and technical analysis...

Therapeutics Acquisition Corp (RACA) - Comprehensive Stock Analysis & Investment Research

Deep dive into Therapeutics Acquisition Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Therapeutics Acquisition Corp, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Therapeutics Acquisition Corp:

Therapeutics Acquisition Corp (Stock Symbol: RACA) .

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Therapeutics Acquisition Corp's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Therapeutics Acquisition Corp: With $16M in annual revenue and -72.4% net margin, the company demonstrates developing profitability.

Annual Revenue: $16 million generating a -72.4% net profit margin .

Market Capitalization: $407 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -258.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Therapeutics Acquisition Corp stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Therapeutics Acquisition Corp: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Therapeutics Acquisition Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Therapeutics Acquisition Corp's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Therapeutics Acquisition Corp: Market positioning analysis based on available financial and operational metrics.

Therapeutics Acquisition Corp strategically competes in the highly dynamic sector, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 55.1% gross margin, indicating strong pricing power and operational efficiency.

Therapeutics Acquisition Corp (RACA) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Therapeutics Acquisition Corp stock analysis.

Loading Therapeutics Acquisition Corp comprehensive fundamental analysis and insider trading data...

Deep dive into Therapeutics Acquisition Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Therapeutics Acquisition Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Therapeutics Acquisition Corp: With a P/E ratio of -34.77, the market sees the stock as potentially undervalued.

P/E Ratio -34.77x
P/B Ratio 86.92x
Market Cap $407M
EPS $-0.30
Book Value/Share $0.12
Revenue/Share $0.41
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Therapeutics Acquisition Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Therapeutics Acquisition Corp: An ROE of -258.5% indicates room for improvement in shareholder value creation.

ROE -258.5%
ROA -35.3%
ROIC -57.2%
Gross Margin 55.1%
Operating Margin -82.1%
Net Margin -72.4%
EBT Margin -111.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Therapeutics Acquisition Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Therapeutics Acquisition Corp: A current ratio of 0.21 suggests potential liquidity concerns.

Current Ratio 0.21x
Quick Ratio 0.20x
D/E Ratio 2.09x
Financial Leverage 7.33x
Interest Coverage -10.3x
Working Capital $-14M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Therapeutics Acquisition Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Therapeutics Acquisition Corp: Free cash flow of $-4M indicates cash challenges that need attention.

Operating Cash Flow $-4M
Free Cash Flow $-4M
FCF/Sales -24.6%
CapEx/Sales 0.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Therapeutics Acquisition Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Therapeutics Acquisition Corp: An asset turnover of 0.49x suggests room for improvement in asset utilization.

Asset Turnover 0.49x
Receivables Turnover 6.2x
Fixed Assets Turnover 2.0x
Days Sales Outstanding 59 days
Payables Period 171 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Therapeutics Acquisition Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Therapeutics Acquisition Corp: With annual revenue of $16M, Therapeutics Acquisition Corp represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $16M
Operating Income $-13M
Net Income $-12M
SG&A Expense $127M
Cost of Goods Sold $45M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 12%
Cash & Short-term Investments 3%
Total Liabilities 86%
Short-term Debt 3%
Accounts Receivable 8%
Dividend & Shareholder Information
Shares Outstanding 39M

Latest Therapeutics Acquisition Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Therapeutics Acquisition Corp (RACA) stock price and investment outlook.

Therapeutics Acquisition Corp Competitors & Peer Analysis -

Comparative analysis of Therapeutics Acquisition Corp against industry peers and competitors in the sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Therapeutics Acquisition Corp Stock Forecast

How accurate are Therapeutics Acquisition Corp stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for RACA predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Therapeutics Acquisition Corp stock price forecasts?

Our analysis considers Therapeutics Acquisition Corp's financial metrics, sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Therapeutics Acquisition Corp a good investment in 2025?

Based on our AI analysis, Therapeutics Acquisition Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Therapeutics Acquisition Corp forecasts updated?

Therapeutics Acquisition Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Therapeutics Acquisition Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Therapeutics Acquisition Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...